Revenue

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Crop Science Revenue	21.61B	22.26B	23.27B
Crop Science Revenue Growth	-2.91%	-4.35%	-7.54%
Pharmaceuticals Revenue	18.01B	18.13B	18.08B
Pharmaceuticals Revenue Growth	-0.66%	0.28%	-6.08%
Consumer Health Revenue	5.91B	5.87B	6.03B
Consumer Health Revenue Growth	0.65%	-2.60%	-0.87%
All Other Segment Revenue	-	327.00M	238.00M
All Other Segment Revenue Growth	-	37.40%	9.68%
Enabling Functions and Consolidation Revenue	-	19.00M	21.00M
Enabling Functions and Consolidation Revenue Growth	-	-9.52%	-

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Europe/Middle East/Africa Revenue	13.60B	13.98B	14.09B
Europe/Middle East/Africa Revenue Growth	-2.71%	-0.75%	-2.38%
North America Revenue	16.67B	16.48B	16.25B
North America Revenue Growth	1.14%	1.37%	-7.50%
Asia/Pacific Revenue	7.89B	8.07B	8.37B
Asia/Pacific Revenue Growth	-2.23%	-3.56%	-11.45%
Latin America Revenue	7.71B	8.08B	8.93B
Latin America Revenue Growth	-4.57%	-9.52%	-3.88%

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Crop Science Adjusted EBITDA	4.34B	4.33B	5.04B
Crop Science Adjusted EBITDA Growth	0.32%	-14.15%	-26.63%
Pharmaceuticals Adjusted EBITDA	4.59B	4.72B	5.19B
Pharmaceuticals Adjusted EBITDA Growth	-2.90%	-9.00%	-11.65%
Consumer Health Adjusted EBITDA	1.40B	1.37B	1.41B
Consumer Health Adjusted EBITDA Growth	2.27%	-3.19%	3.22%
All Other Segment Adjusted EBITDA	-	62.00M	163.00M
All Other Segment Adjusted EBITDA Growth	-	-61.96%	7.95%
Enabling Functions and Consolidation Adjusted EBITDA	-	-352.00M	-95.00M

Updated Sep 30, 2025. Data Source: Fiscal.ai.